HANGZHOU, China, Feb. 24, 2025 /PRNewswire-PRWeb/ -- Hangzhou Viablife Biotech Co., Ltd., a leading innovator in biosynthesis and biofermentation technologies for food and dietary supplement ingredients, proudly announces that its highly-scalable biosynthesized Hydroxytyrosol has received "No Objection" from the U.S. Food and Drug Administration (FDA) for its Generally Recognized as Safe (GRAS) Notification on a scientific basis.
Hangzhou Viablife Biotech Co., Ltd., a leading innovator in biosynthesis and biofermentation technologies for food and dietary supplement ingredients, proudly announces that its highly-scalable biosynthesized Hydroxytyrosol has received "No Objection" from the U.S. Food and Drug Administration (FDA) for its Generally Recognized as Safe (GRAS) Notification on a scientific basis.
This achievement was made possible through Viablife's collaboration with REJIMUS, INC., a top-tier FDA regulatory consultancy based in the United States, having a dedicated department specializing in GRAS and NDI Notifications with an unprecedented track record of successful first-time FDA Notifications. With REJIMUS' expertise in GRAS assessments, regulatory submissions, and the business strategies around getting ingredients to market, Viablife successfully navigated the rigorous scientific and safety evaluation process required by the FDA.
Hydroxytyrosol, a powerful polyphenol is naturally found in olives, and is well known for its potent antioxidant properties and significant health benefits, particularly in cardiovascular and neuroprotective support. Viablife's patented biosynthesis technology enables the sustainable and efficient production of high-purity Hydroxytyrosol at commercial scale, offering an environmentally friendly alternative to traditional extraction methods and competing ingredients in the marketplace. This milestone reinforces Viablife's commitment to advancing sustainable, science-driven ingredient solutions for global markets. Viablife's Hydroxytyrosol is for use as an antioxidant in various foods such as butter, margarine, oil, and shortening, salad dressing, mayonnaise and mayonnaise-type sandwich spreads as well as ready-to-drink sports drinks, "energy" drinks, milk-based meal replacements, flavored water, and fruit flavored drinks, fruit juices, fruit nectars, and vegetable juices.
"Our mission at Viablife is to revolutionize the way bioactive compounds are produced, making them more sustainable and accessible to the industry," said Justin Han, Director of Health and Nutrition Division at Hangzhou Viablife Biotech Co., Ltd. "Achieving an FDA No Objection status for Hydroxytyrosol is a testament to the strategy, safety, efficacy, and scalability of our technological approach as well as overall capabilities. We are grateful to the team at REJIMUS for their incredible regulatory guidance and unwavering support throughout this process."
"Viablife's success in obtaining GRAS Status from the FDA reflects the company's dedication to high-quality, purpose-driven food ingredient innovation and services, which perfectly aligns with our mission," said Brandon M. Griffin, CEO at REJIMUS, INC. "We are extremely proud to have supported this effort from start to finish and look forward to seeing this ingredient and the Viablife team flourish."
With this regulatory clearance, Viablife is positioned to greatly expand its market presence in the U.S., offering product manufacturers and leading CPG brands a reliable, sustainable source of high-purity Hydroxytyrosol for a wide range of traditional foods and beverages.
Hangzhou Viablife Biotech Co., Ltd.:
Viablife is a hightech enterprise that is specialized in enzymatic synthesis and biomanufacturing of active pharmaceutical ingredients, fine chemicals, natural dyes, advanced intermediates, and food ingredients. To learn more about Viablife's current innovations, ingredients and other resources to U.S. customers, please visit: http://www.viablife.com or http://www.viablife.net
About REJIMUS, Inc.:
REJIMUS, INC. is a preeminent FDA regulatory management consultancy enabling companies in the Food, Dietary Supplement, Cosmetic and Homeopathic/OTC industries to achieve faster time-to-market for novel ingredients and finished consumer product goods with less legal and regulatory risks, while optimizing their quality operations and overall supply-chain. For more information on the markets served and service offerings, please visit: https://www.rejimus.com
Media Contact
Dianne Strickland, REJIMUS, INC., 1 682-267-1204, [email protected], https://www.rejimus.com
SOURCE REJIMUS, INC.
Share this article